Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 牙醫專業學院
  4. 口腔生物科學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/95119
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor郭瑋庭zh_TW
dc.contributor.advisorWei-Ting Kuoen
dc.contributor.author林家瑩zh_TW
dc.contributor.authorChia-Ying Linen
dc.date.accessioned2024-08-29T16:09:46Z-
dc.date.available2024-08-30-
dc.date.copyright2024-08-29-
dc.date.issued2024-
dc.date.submitted2024-08-06-
dc.identifier.citationAnderson, J. M., and C. M. Van Itallie. 2009. 'Physiology and function of the tight junction', Cold Spring Harb Perspect Biol, 1: a002584.
Arsura, M., G. R. Panta, J. D. Bilyeu, L. G. Cavin, M. A. Sovak, A. A. Oliver, V. Factor, R. Heuchel, F. Mercurio, S. S. Thorgeirsson, and G. E. Sonenshein. 2003. 'Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation', Oncogene, 22: 412-25.
Atfi, A., M. Buisine, A. Mazars, and C. Gespach. 1997. 'Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway', J Biol Chem, 272: 24731-4.
Balda, M. S., C. Flores-Maldonado, M. Cereijido, and K. Matter. 2000. 'Multiple domains of occludin are involved in the regulation of paracellular permeability', J Cell Biochem, 78: 85-96.
Balda, M. S., J. A. Whitney, C. Flores, S. Gonzalez, M. Cereijido, and K. Matter. 1996. 'Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein', J Cell Biol, 134: 1031-49.
Barrios-Rodiles, M., K. R. Brown, B. Ozdamar, R. Bose, Z. Liu, R. S. Donovan, F. Shinjo, Y. Liu, J. Dembowy, I. W. Taylor, V. Luga, N. Przulj, M. Robinson, H. Suzuki, Y. Hayashizaki, I. Jurisica, and J. L. Wrana. 2005. 'High-throughput mapping of a dynamic signaling network in mammalian cells', Science, 307: 1621-5.
Bian, Y., A. Terse, J. Du, B. Hall, A. Molinolo, P. Zhang, W. Chen, K. C. Flanders, J. S. Gutkind, L. M. Wakefield, and A. B. Kulkarni. 2009. 'Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway', Cancer Res, 69: 5918-26.
Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. 1990. 'Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1', Nature, 346: 371-4.
Brenner, D., H. Blaser, and T. W. Mak. 2015. 'Regulation of tumour necrosis factor signalling: live or let die', Nat Rev Immunol, 15: 362-74.
Brenner, D., and T. W. Mak. 2009. 'Mitochondrial cell death effectors', Curr Opin Cell Biol, 21: 871-7.
Broekelmann, T. J., A. H. Limper, T. V. Colby, and J. A. McDonald. 1991. 'Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis', Proc Natl Acad Sci U S A, 88: 6642-6.
Buschmann, M. M., L. Shen, H. Rajapakse, D. R. Raleigh, Y. Wang, Y. Wang, A. Lingaraju, J. Zha, E. Abbott, E. M. McAuley, L. A. Breskin, L. Wu, K. Anderson, J. R. Turner, and C. R. Weber. 2013. 'Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux', Mol Biol Cell, 24: 3056-68.
Campbell, H. K., J. L. Maiers, and K. A. DeMali. 2017. 'Interplay between tight junctions & adherens junctions', Exp Cell Res, 358: 39-44.
Canovas, B., and A. R. Nebreda. 2021. 'Diversity and versatility of p38 kinase signalling in health and disease', Nat Rev Mol Cell Biol, 22: 346-66.
Capece, D., D. Verzella, I. Flati, P. Arboretto, J. Cornice, and G. Franzoso. 2022. 'NF-kappaB: blending metabolism, immunity, and inflammation', Trends Immunol, 43: 757-75.
Chen, X. H., L. L. Lu, H. P. Ke, Z. C. Liu, H. F. Wang, W. Wei, Y. F. Qi, H. S. Wang, S. H. Cai, and J. Du. 2017. 'The TGF-beta-induced up-regulation of NKG2DLs requires AKT/GSK-3beta-mediated stabilization of SP1', J Cell Mol Med, 21: 860-70.
Coker, R. K., G. J. Laurent, P. K. Jeffery, R. M. du Bois, C. M. Black, and R. J. McAnulty. 2001. 'Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung', Thorax, 56: 549-56.
Corrin, B., D. Butcher, B. J. McAnulty, R. M. Dubois, C. M. Black, G. J. Laurent, and N. K. Harrison. 1994. 'Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders', Histopathology, 24: 145-50.
Cummins, P. M. 2012. 'Occludin: one protein, many forms', Mol Cell Biol, 32: 242-50.
D'Alessandro-Gabazza, C. N., T. Kobayashi, D. Boveda-Ruiz, T. Takagi, M. Toda, P. Gil-Bernabe, Y. Miyake, A. Yasukawa, Y. Matsuda, N. Suzuki, H. Saito, Y. Yano, A. Fukuda, T. Hasegawa, H. Toyobuku, S. I. Rennard, P. D. Wagner, J. Morser, Y. Takei, O. Taguchi, and E. C. Gabazza. 2012. 'Development and preclinical efficacy of novel transforming growth factor-beta1 short interfering RNAs for pulmonary fibrosis', Am J Respir Cell Mol Biol, 46: 397-406.
Dammeier, J., M. Brauchle, W. Falk, G. R. Grotendorst, and S. Werner. 1998. 'Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease?', Int J Biochem Cell Biol, 30: 909-22.
David, C. J., Y. H. Huang, M. Chen, J. Su, Y. Zou, N. Bardeesy, C. A. Iacobuzio-Donahue, and J. Massague. 2016. 'TGF-beta Tumor Suppression through a Lethal EMT', Cell, 164: 1015-30.
Deng, Z., T. Fan, C. Xiao, H. Tian, Y. Zheng, C. Li, and J. He. 2024. 'TGF-beta signaling in health, disease, and therapeutics', Signal Transduct Target Ther, 9: 61.
Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. 'Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells', Nature, 316: 701-5.
Di Guglielmo, G. M., C. Le Roy, A. F. Goodfellow, and J. L. Wrana. 2003. 'Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover', Nat Cell Biol, 5: 410-21.
Edelblum, K. L., and J. R. Turner. 2009. 'The tight junction in inflammatory disease: communication breakdown', Curr Opin Pharmacol, 9: 715-20.
Elmore, S. 2007. 'Apoptosis: a review of programmed cell death', Toxicol Pathol, 35: 495-516.
Fichtner-Feigl, S., I. J. Fuss, C. A. Young, T. Watanabe, E. K. Geissler, H. J. Schlitt, A. Kitani, and W. Strober. 2007. 'Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis', J Immunol, 178: 5859-70.
Fletcher, S. J., M. Iqbal, S. Jabbari, D. Stekel, and J. Z. Rappoport. 2014. 'Analysis of occludin trafficking, demonstrating continuous endocytosis, degradation, recycling and biosynthetic secretory trafficking', PLoS One, 9: e111176.
Franke, T. F. 2008. 'PI3K/Akt: getting it right matters', Oncogene, 27: 6473-88.
Galluzzi, L., M. C. Maiuri, I. Vitale, H. Zischka, M. Castedo, L. Zitvogel, and G. Kroemer. 2007. 'Cell death modalities: classification and pathophysiological implications', Cell Death Differ, 14: 1237-43.
Galluzzi, L., I. Vitale, J. M. Abrams, E. S. Alnemri, E. H. Baehrecke, M. V. Blagosklonny, T. M. Dawson, V. L. Dawson, W. S. El-Deiry, S. Fulda, E. Gottlieb, D. R. Green, M. O. Hengartner, O. Kepp, R. A. Knight, S. Kumar, S. A. Lipton, X. Lu, F. Madeo, W. Malorni, P. Mehlen, G. Nunez, M. E. Peter, M. Piacentini, D. C. Rubinsztein, Y. Shi, H. U. Simon, P. Vandenabeele, E. White, J. Yuan, B. Zhivotovsky, G. Melino, and G. Kroemer. 2012. 'Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012', Cell Death Differ, 19: 107-20.
Ganz, T. 2003. 'Defensins: antimicrobial peptides of innate immunity', Nat Rev Immunol, 3: 710-20.
Guasch, G., M. Schober, H. A. Pasolli, E. B. Conn, L. Polak, and E. Fuchs. 2007. 'Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia', Cancer Cell, 12: 313-27.
Hahm, K. B., K. M. Lee, Y. B. Kim, W. S. Hong, W. H. Lee, S. U. Han, M. W. Kim, B. O. Ahn, T. Y. Oh, M. H. Lee, J. Green, and S. J. Kim. 2002. 'Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice', Aliment Pharmacol Ther, 16 Suppl 2: 115-27.
Hamidi, A., V. von Bulow, R. Hamidi, N. Winssinger, S. Barluenga, C. H. Heldin, and M. Landstrom. 2012. 'Polyubiquitination of transforming growth factor beta (TGFbeta)-associated kinase 1 mediates nuclear factor-kappaB activation in response to different inflammatory stimuli', J Biol Chem, 287: 123-33.
Han, G., S. L. Lu, A. G. Li, W. He, C. L. Corless, M. Kulesz-Martin, and X. J. Wang. 2005. 'Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis', J Clin Invest, 115: 1714-23.
He, W. Q., J. Wang, J. Y. Sheng, J. M. Zha, W. V. Graham, and J. R. Turner. 2020. 'Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis', Int J Mol Sci, 21.
Heldin, C. H., and A. Moustakas. 2016. 'Signaling Receptors for TGF-beta Family Members', Cold Spring Harb Perspect Biol, 8.
Heller, F., P. Florian, C. Bojarski, J. Richter, M. Christ, B. Hillenbrand, J. Mankertz, A. H. Gitter, N. Burgel, M. Fromm, M. Zeitz, I. Fuss, W. Strober, and J. D. Schulzke. 2005. 'Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution', Gastroenterology, 129: 550-64.
Hishikawa, K., B. S. Oemar, F. C. Tanner, T. Nakaki, T. F. Luscher, and T. Fujii. 1999. 'Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7', J Biol Chem, 274: 37461-6.
Horowitz, A., S. D. Chanez-Paredes, X. Haest, and J. R. Turner. 2023. 'Paracellular permeability and tight junction regulation in gut health and disease', Nat Rev Gastroenterol Hepatol, 20: 417-32.
Howat, W. J., S. T. Holgate, and P. M. Lackie. 2002. 'TGF-beta isoform release and activation during in vitro bronchial epithelial wound repair', Am J Physiol Lung Cell Mol Physiol, 282: L115-23.
Hsu, H., H. B. Shu, M. G. Pan, and D. V. Goeddel. 1996. 'TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways', Cell, 84: 299-308.
Hsu, H., J. Xiong, and D. V. Goeddel. 1995. 'The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation', Cell, 81: 495-504.
Ijichi, H., A. Chytil, A. E. Gorska, M. E. Aakre, Y. Fujitani, S. Fujitani, C. V. Wright, and H. L. Moses. 2006. 'Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression', Genes Dev, 20: 3147-60.
Jang, C. W., C. H. Chen, C. C. Chen, J. Y. Chen, Y. H. Su, and R. H. Chen. 2002. 'TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase', Nat Cell Biol, 4: 51-8.
Kerr, J. F., A. H. Wyllie, and A. R. Currie. 1972. 'Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics', Br J Cancer, 26: 239-57.
Kim, B. C., M. Mamura, K. S. Choi, B. Calabretta, and S. J. Kim. 2002. 'Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells', Mol Cell Biol, 22: 1369-78.
Kim, S. G., H. S. Jong, T. Y. Kim, J. W. Lee, N. K. Kim, S. H. Hong, and Y. J. Bang. 2004. 'Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells', Mol Biol Cell, 15: 420-34.
Kitajiri, S., T. Katsuno, H. Sasaki, J. Ito, M. Furuse, and S. Tsukita. 2014. 'Deafness in occludin-deficient mice with dislocation of tricellulin and progressive apoptosis of the hair cells', Biol Open, 3: 759-66.
Kosciuczuk, E. M., P. Lisowski, J. Jarczak, N. Strzalkowska, A. Jozwik, J. Horbanczuk, J. Krzyzewski, L. Zwierzchowski, and E. Bagnicka. 2012. 'Cathelicidins: family of antimicrobial peptides. A review', Mol Biol Rep, 39: 10957-70.
Kowalczyk, A. P., and K. J. Green. 2013. 'Structure, function, and regulation of desmosomes', Prog Mol Biol Transl Sci, 116: 95-118.
Krug, S. M., J. D. Schulzke, and M. Fromm. 2014. 'Tight junction, selective permeability, and related diseases', Semin Cell Dev Biol, 36: 166-76.
Kuo, W. T., L. Shen, L. Zuo, N. Shashikanth, Mldm Ong, L. Wu, J. Zha, K. L. Edelblum, Y. Wang, Y. Wang, S. P. Nilsen, and J. R. Turner. 2019. 'Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression', Gastroenterology, 157: 1323-37.
Kuwabara, H., Y. Kokai, T. Kojima, R. Takakuwa, M. Mori, and N. Sawada. 2001. 'Occludin regulates actin cytoskeleton in endothelial cells', Cell Struct Funct, 26: 109-16.
Landstrom, M., N. E. Heldin, S. Bu, A. Hermansson, S. Itoh, P. ten Dijke, and C. H. Heldin. 2000. 'Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells', Curr Biol, 10: 535-8.
Landy, J., E. Ronde, N. English, S. K. Clark, A. L. Hart, S. C. Knight, P. J. Ciclitira, and H. O. Al-Hassi. 2016. 'Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer', World J Gastroenterol, 22: 3117-26.
Larisch, S., Y. Yi, R. Lotan, H. Kerner, S. Eimerl, W. Tony Parks, Y. Gottfried, S. Birkey Reffey, M. P. de Caestecker, D. Danielpour, N. Book-Melamed, R. Timberg, C. S. Duckett, R. J. Lechleider, H. Steller, J. Orly, S. J. Kim, and A. B. Roberts. 2000. 'A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif', Nat Cell Biol, 2: 915-21.
Lavoie, H., J. Gagnon, and M. Therrien. 2020. 'ERK signalling: a master regulator of cell behaviour, life and fate', Nat Rev Mol Cell Biol, 21: 607-32.
Lavrik, I., A. Golks, and P. H. Krammer. 2005. 'Death receptor signaling', J Cell Sci, 118: 265-7.
Li, M., M. S. Krishnaveni, C. Li, B. Zhou, Y. Xing, A. Banfalvi, A. Li, V. Lombardi, O. Akbari, Z. Borok, and P. Minoo. 2011. 'Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis', J Clin Invest, 121: 277-87.
Lund, P. K., and C. C. Zuniga. 2001. 'Intestinal fibrosis in human and experimental inflammatory bowel disease', Curr Opin Gastroenterol, 17: 318-23.
Madara, J. L., S. Nash, R. Moore, and K. Atisook. 1990. 'Structure and function of the intestinal epithelial barrier in health and disease', Monogr Pathol: 306-24.
Marchiando, A. M., L. Shen, W. V. Graham, C. R. Weber, B. T. Schwarz, J. R. Austin, 2nd, D. R. Raleigh, Y. Guan, A. J. Watson, M. H. Montrose, and J. R. Turner. 2010. 'Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo', J Cell Biol, 189: 111-26.
Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, and et al. 1995. 'Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability', Science, 268: 1336-8.
Mathur, R., M. M. Alam, X. F. Zhao, Y. Liao, J. Shen, S. Morgan, T. Huang, H. Lee, E. Lee, Y. Huang, and X. Zhu. 2019. 'Induction of autophagy in Cx3cr1(+) mononuclear cells limits IL-23/IL-22 axis-mediated intestinal fibrosis', Mucosal Immunol, 12: 612-23.
McCarthy, K. M., I. B. Skare, M. C. Stankewich, M. Furuse, S. Tsukita, R. A. Rogers, R. D. Lynch, and E. E. Schneeberger. 1996. 'Occludin is a functional component of the tight junction', J Cell Sci, 109 ( Pt 9): 2287-98.
Mozes, M. M., E. P. Bottinger, T. A. Jacot, and J. B. Kopp. 1999. 'Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice', J Am Soc Nephrol, 10: 271-80.
Muniz, L. R., C. Knosp, and G. Yeretssian. 2012. 'Intestinal antimicrobial peptides during homeostasis, infection, and disease', Front Immunol, 3: 310.
Nagy, P., Z. Schaff, and K. Lapis. 1991. 'Immunohistochemical detection of transforming growth factor-beta 1 in fibrotic liver diseases', Hepatology, 14: 269-73.
Nakao, A., M. Fujii, R. Matsumura, K. Kumano, Y. Saito, K. Miyazono, and I. Iwamoto. 1999. 'Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice', J Clin Invest, 104: 5-11.
Nomikou, E., M. Livitsanou, C. Stournaras, and D. Kardassis. 2018. 'Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases', Cell Mol Life Sci, 75: 2111-24.
Noren, N. K., B. P. Liu, K. Burridge, and B. Kreft. 2000. 'p120 catenin regulates the actin cytoskeleton via Rho family GTPases', J Cell Biol, 150: 567-80.
Nusrat, A., J. A. Chen, C. S. Foley, T. W. Liang, J. Tom, M. Cromwell, C. Quan, and R. J. Mrsny. 2000. 'The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction', J Biol Chem, 275: 29816-22.
Pabst, O. 2012. 'New concepts in the generation and functions of IgA', Nat Rev Immunol, 12: 821-32.
Papadimitriou, E., D. Kardassis, A. Moustakas, and C. Stournaras. 2011. 'TGFbeta-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2', Cell Physiol Biochem, 28: 229-38.
Perlman, R., W. P. Schiemann, M. W. Brooks, H. F. Lodish, and R. A. Weinberg. 2001. 'TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation', Nat Cell Biol, 3: 708-14.
Peter, M. E., and P. H. Krammer. 2003. 'The CD95(APO-1/Fas) DISC and beyond', Cell Death Differ, 10: 26-35.
Philips, R. L., Y. Wang, H. Cheon, Y. Kanno, M. Gadina, V. Sartorelli, C. M. Horvath, J. E. Darnell, Jr., G. R. Stark, and J. J. O'Shea. 2022. 'The JAK-STAT pathway at 30: Much learned, much more to do', Cell, 185: 3857-76.
Pierce, D. F., Jr., A. E. Gorska, A. Chytil, K. S. Meise, D. L. Page, R. J. Coffey, Jr., and H. L. Moses. 1995. 'Mammary tumor suppression by transforming growth factor beta 1 transgene expression', Proc Natl Acad Sci U S A, 92: 4254-8.
Pierucci-Alves, F., S. Yi, and B. D. Schultz. 2012. 'Transforming growth factor beta 1 induces tight junction disruptions and loss of transepithelial resistance across porcine vas deferens epithelial cells', Biol Reprod, 86: 36.
Planchon, S., C. Fiocchi, V. Takafuji, and J. K. Roche. 1999. 'Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists', J Cell Physiol, 181: 55-66.
Rachmilewitz, D., J. S. Stamler, F. Karmeli, M. E. Mullins, D. J. Singel, J. Loscalzo, R. J. Xavier, and D. K. Podolsky. 1993. 'Peroxynitrite-induced rat colitis--a new model of colonic inflammation', Gastroenterology, 105: 1681-8.
Rieder, F., S. Kessler, M. Sans, and C. Fiocchi. 2012. 'Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease', Am J Physiol Gastrointest Liver Physiol, 303: G786-801.
Saitou, M., K. Fujimoto, Y. Doi, M. Itoh, T. Fujimoto, M. Furuse, H. Takano, T. Noda, and S. Tsukita. 1998. 'Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions', J Cell Biol, 141: 397-408.
Saitou, M., M. Furuse, H. Sasaki, J. D. Schulzke, M. Fromm, H. Takano, T. Noda, and S. Tsukita. 2000. 'Complex phenotype of mice lacking occludin, a component of tight junction strands', Mol Biol Cell, 11: 4131-42.
Sakakibara, A., M. Furuse, M. Saitou, Y. Ando-Akatsuka, and S. Tsukita. 1997. 'Possible involvement of phosphorylation of occludin in tight junction formation', J Cell Biol, 137: 1393-401.
Schmidt, A., and A. Hall. 2002. 'Guanine nucleotide exchange factors for Rho GTPases: turning on the switch', Genes Dev, 16: 1587-609.
Schulzke, J. D., A. H. Gitter, J. Mankertz, S. Spiegel, U. Seidler, S. Amasheh, M. Saitou, S. Tsukita, and M. Fromm. 2005. 'Epithelial transport and barrier function in occludin-deficient mice', Biochim Biophys Acta, 1669: 34-42.
Shen, L., C. R. Weber, D. R. Raleigh, D. Yu, and J. R. Turner. 2011. 'Tight junction pore and leak pathways: a dynamic duo', Annu Rev Physiol, 73: 283-309.
Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, D. R. Green, and S. J. Martin. 1999. 'Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner', J Cell Biol, 144: 281-92.
Stamatovic, S. M., A. M. Johnson, N. Sladojevic, R. F. Keep, and A. V. Andjelkovic. 2017. 'Endocytosis of tight junction proteins and the regulation of degradation and recycling', Ann N Y Acad Sci, 1397: 54-65.
Steiner, M. S., and E. R. Barrack. 1992. 'Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro', Mol Endocrinol, 6: 15-25.
Tachibana, I., M. Imoto, P. N. Adjei, G. J. Gores, M. Subramaniam, T. C. Spelsberg, and R. Urrutia. 1997. 'Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells', J Clin Invest, 99: 2365-74.
Takaku, K., M. Oshima, H. Miyoshi, M. Matsui, M. F. Seldin, and M. M. Taketo. 1998. 'Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes', Cell, 92: 645-56.
Takiishi, T., C. I. M. Fenero, and N. O. S. Camara. 2017. 'Intestinal barrier and gut microbiota: Shaping our immune responses throughout life', Tissue Barriers, 5: e1373208.
Tang, B., M. Vu, T. Booker, S. J. Santner, F. R. Miller, M. R. Anver, and L. M. Wakefield. 2003. 'TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression', J Clin Invest, 112: 1116-24.
Tang, L. Y., M. Heller, Z. Meng, L. R. Yu, Y. Tang, M. Zhou, and Y. E. Zhang. 2017. 'Transforming Growth Factor-beta (TGF-beta) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway', J Biol Chem, 292: 4302-12.
Tu, W. H., T. Z. Thomas, N. Masumori, N. A. Bhowmick, A. E. Gorska, Y. Shyr, S. Kasper, T. Case, R. L. Roberts, S. B. Shappell, H. L. Moses, and R. J. Matusik. 2003. 'The loss of TGF-beta signaling promotes prostate cancer metastasis', Neoplasia, 5: 267-77.
Turner, J. R. 2009. 'Intestinal mucosal barrier function in health and disease', Nat Rev Immunol, 9: 799-809.
Turner, J. R., B. K. Rill, S. L. Carlson, D. Carnes, R. Kerner, R. J. Mrsny, and J. L. Madara. 1997. 'Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation', Am J Physiol, 273: C1378-85.
Tzavlaki, K., and A. Moustakas. 2020. 'TGF-beta Signaling', Biomolecules, 10.
Van Itallie, C. M., and J. M. Anderson. 1997. 'Occludin confers adhesiveness when expressed in fibroblasts', J Cell Sci, 110: 1113-21.
Van Itallie, C. M., A. S. Fanning, J. Holmes, and J. M. Anderson. 2010. 'Occludin is required for cytokine-induced regulation of tight junction barriers', J Cell Sci, 123: 2844-52.
Vogelmann, R., D. Ruf, M. Wagner, G. Adler, and A. Menke. 2001. 'Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model', Am J Physiol Gastrointest Liver Physiol, 280: G164-72.
Wajant, H. 2002. 'The Fas signaling pathway: more than a paradigm', Science, 296: 1635-6.
Walia, B., L. Wang, D. Merlin, and S. V. Sitaraman. 2003. 'TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2', FASEB J, 17: 2130-2.
Wang, H., M. Chen, X. Sang, X. You, Y. Wang, I. C. Paterson, W. Hong, and X. Yang. 2020. 'Development of small molecule inhibitors targeting TGF-beta ligand and receptor: Structures, mechanism, preclinical studies and clinical usage', Eur J Med Chem, 191: 112154.
Wang, X. J., K. M. Liefer, S. Tsai, B. W. O'Malley, and D. R. Roop. 1999. 'Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis', Proc Natl Acad Sci U S A, 96: 8483-8.
Welch, D. R., A. Fabra, and M. Nakajima. 1990. 'Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential', Proc Natl Acad Sci U S A, 87: 7678-82.
Wong, V. 1997. 'Phosphorylation of occludin correlates with occludin localization and function at the tight junction', Am J Physiol, 273: C1859-67.
Wong, V., and B. M. Gumbiner. 1997. 'A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier', J Cell Biol, 136: 399-409.
Yamamoto, T., N. A. Noble, A. H. Cohen, C. C. Nast, A. Hishida, L. I. Gold, and W. A. Border. 1996. 'Expression of transforming growth factor-beta isoforms in human glomerular diseases', Kidney Int, 49: 461-9.
Yanagisawa, K., H. Osada, A. Masuda, M. Kondo, T. Saito, Y. Yatabe, K. Takagi, T. Takahashi, and T. Takahashi. 1998. 'Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells', Oncogene, 17: 1743-7.
Yang, Y. A., B. Tang, G. Robinson, L. Hennighausen, S. G. Brodie, C. X. Deng, and L. M. Wakefield. 2002. 'Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta', Cell Growth Differ, 13: 123-30.
Yao, J. C., K. A. Oetjen, T. Wang, H. Xu, G. Abou-Ezzi, J. R. Krambs, S. Uttarwar, E. J. Duncavage, and D. C. Link. 2022. 'TGF-beta signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche', J Clin Invest, 132.
Zeissig, S., N. Burgel, D. Gunzel, J. Richter, J. Mankertz, U. Wahnschaffe, A. J. Kroesen, M. Zeitz, M. Fromm, and J. D. Schulzke. 2007. 'Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease', Gut, 56: 61-72.
Zeke, A., M. Misheva, A. Remenyi, and M. A. Bogoyevitch. 2016. 'JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships', Microbiol Mol Biol Rev, 80: 793-835.
Zhang, H., I. Ozaki, T. Mizuta, H. Hamajima, T. Yasutake, Y. Eguchi, H. Ideguchi, K. Yamamoto, and S. Matsuhashi. 2006. 'Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma', Oncogene, 25: 6101-12.
Zhang, Q., F. Cui, L. Fang, J. Hong, B. Zheng, and J. Z. Zhang. 2013. 'TNF-alpha impairs differentiation and function of TGF-beta-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway', J Mol Cell Biol, 5: 85-98.
Zhang, X., Y. Ma, T. You, X. Tian, H. Zhang, Q. Zhu, and W. Zhang. 2015. 'Roles of TGF-beta/Smad signaling pathway in pathogenesis and development of gluteal muscle contracture', Connect Tissue Res, 56: 9-17.
Zhao, J., W. Shi, Y. L. Wang, H. Chen, P. Bringas, Jr., M. B. Datto, J. P. Frederick, X. F. Wang, and D. Warburton. 2002. 'Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice', Am J Physiol Lung Cell Mol Physiol, 282: L585-93.
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/95119-
dc.description.abstractOccludin 是第一個被發現調節上皮細胞屏障通透性的跨膜緊密連接蛋白。臨床數據顯示,在發炎性腸道疾病 (IBD) 患者中,潰瘍組織有Occludin表現量下降現象。我們先前發現,缺乏Occludin可透過降低caspase-3的mRNA和蛋白質表現來減少細胞死亡,這個過程對於維持黏膜平衡至關重要,但其中調節的分子機制尚不清楚。Occludin與TGFβR結合促進調節TGFβ引起的緊密連接溶解現象。 Occludin可能抑制依賴TGFβ的SMAD3訊息途徑,對調控caspase-3在維持黏膜穩態中有著重要作用。
目標:探討OCLN/TGFβR訊號如何調控上皮細胞凋亡caspase-3的分子機制。
材料與方法:我們使用RT-qPCR、西方墨點法和免疫螢光染色技術在腸道上皮WT、OCLN KD和OCLN KO Caco-2細胞中檢測包括OCLN、TGFβR、SMAD3和CASP3在內的分子訊號,使用鄰近連接測定法 (PLA) 檢測蛋白質交互作用。TGFβR抑制劑SB-525334和LY2109761用於研究OCLN/TGFβR訊號在調控caspase-3表現的特異性。透過腸道上皮細胞特異性Occludin敲除小鼠 (Ocln KOIEC) 和WT小鼠給予硫酸葡聚醣 (DSS) 誘發結腸炎模型,並分析結腸組織中Ocln、Tgfbr/Smad和凋亡訊號的轉錄體表現。最後,我們利用基因表現綜合資料集 (GEO) 分析健康和IBD患者的上述分子訊號表現以確認體外細胞研究發現。
結果:首先確認OCLN KD和OCLN KO Caco-2細胞具備Occludin缺乏現象,這些細胞的跨膜屏障通透性遠高於WT Caco-2細胞。缺乏Occludin導致caspase-3的轉錄和蛋白質表現量降低,而TGFβR和SMAD3表現量保持不變。在基底外側給予TGFβ不會改變TGFβR的表現量。PLA顯示,TGFβR與Occludin的交互作用會減少Occludin與早期內吞標記物EEA1的內吞。Occludin缺乏細胞中的SMAD3表現不受TGFβ處理影響。然而,它增加了SMAD3的核轉位並減少了caspase-3的生成。這些數據顯示,Occludin與TGFβR相互作用可能透過阻礙Occludin內化來抑制TGFβ/SMAD3訊息途徑,進而影響caspase-3的生成。TGFβR激酶活性的藥理抑制劑SB-525334和LY2109761不會影響TGFβR與Occludin的相互作用。在TGFβR抑制後,與TGFβ處理相比,Occludin與EEA1的交互作用增加,SMAD3的核轉位減少。這些結果顯示Occludin與TGFβR的相互作用發生在TGFβR磷酸化之前,SMAD3訊號在調節caspase-3訊號中扮演著重要角色,這對於維持黏膜穩態至關重要。在DSS誘導的結腸炎模型中,Ocln KOIEC小鼠的Casp3表現量降低,Tgfb/Smad3訊號沒有變化,與體外細胞研究結果一致。最後,IBD患者的GEO資料集顯示OCLN表現量降低,CASP3升高,伴隨著上皮細胞標記KRT8表現量降低,顯示在IBD患者需要進一步針對上皮細胞的研究。
結論:這項研究發現Occludin缺乏對凋亡調節的可能新機制,它還顯示Occludin表現量下降如何透過減少caspase-3合成從而降低凋亡。Occludin的內吞現象和TGFβ/SMAD3訊號在這複雜機制中扮演重要角色,這一途徑可能是一種在病理情況下減少上皮組織損傷的適應性策略。
zh_TW
dc.description.abstractOccludin is the first transmembrane tight junction protein found to regulate epithelial cell barrier permeability. Clinical evidence of inflammatory illness (IBD) shows destructured Occludin expression in ulcer tissue. We previously found that the absence of Occludin reduces cellular death via reducing mRNA and protein expression of caspase-3. This procedure is essential for mucosal lining balance. The mechanism underlying this regulation is unclear. Occludin binding to TGFβR facilitates the dissolution of tight junctions. Occludin may inhibit the TGFβ-dependent SMAD3 signaling pathway, which controls the role of caspase-3 role in maintaining mucosal homeostasis.
Objective: To explore the mechanism by which OCLN/TGFβR signaling governs epithelial apoptotic caspase-3.
Materials and Methods: We examined molecular signals including OCLN, TGFβR, SMAD3, and CASP3 in intestinal epithelial WT, OCLN KD, and OCLN KO Caco-2 cells using RT-qPCR, Western blotting, and immunostaining. The protein interactions was measured by proximity ligation assay (PLA). TGFβR inhibitors SB-525334 and LY2109761 were used to study the specificity of OCLN/TGFβR signaling in controlling caspase-3 expression. Dextran sulfate sodium (DSS) was given to intestinal-specific Occludin knockout (Ocln KOIEC) and WT littermates to create a colitis model and analyze transcription of Ocln, Tgfbr/Smad, and apoptotic signals in colonic tissues. The Gene Expression Omnibus (GEO) dataset of healthy and IBD patients was also investigated to confirm in vitro findings.
Results: OCLN KD and OCLN KO Caco-2 cells showed Occludin deficient efficacy. These cells had far higher barrier permeability than WT. Lack of Occludin resulted in lower caspase-3 transcript and protein levels, while TGFβR and SMAD3 levels remained unchanged. Applying TGFβ to the basolateral side did not change the quantity of TGFβR. PLA showed that TGFβR contact with Occludin decreased its internalization with early endosomal EEA1, as indicated by the interaction. SMAD3 expression was unaffected by TGFβ treatment in Occludin-deficient cells. However, it increased SMAD3 nucleus translocation and decreased caspase-3 production. These data suggest that Occludin-TGFβR interaction may inhibit the TGFβ/SMAD3 pathway by hindering Occludin internalization, which affects caspase-3 production. Pharmacological inhibitors SB-525334 and LY2109761, targeting TGFβR kinase activity, did not affect the interaction between TGFβR and Occludin. After TGFβR inhibition, Occludin interaction with EEA1 increased and SMAD3 nuclear translocation decreased compared to TGFβ treatment. Occludin and TGFβR interact before phosphorylation, suggesting that SMAD3 signals play a vital role in regulating caspase-3 signals, which maintain mucosal homeostasis. In the DSS-induced colitis paradigm, Ocln KOIEC mice had downregulated Casp3 and unaltered Tgfb/Smad3 signals, confirming in vitro studies. Finally, the GEO dataset of IBD patients showed downregulation of OCLN, elevated CASP3, and low epithelial marker KRT8, suggesting that further investigation of IBD epithelia needs to be conducted.
Conclusions: This study discovers new Occludin deficient effects on apoptosis regulation. It also shows how dropped Occludin levels reduce caspase-3 synthesis in turn lowering apoptosis. Occludin endocytosis and TGFβ/SMAD3 signaling play a significant role in the complicated mechanism. This pathway may be an adaptive strategy to reduce epithelial tissue damage under pathogenic situations.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-29T16:09:46Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2024-08-29T16:09:46Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents目次
口試委員會審定書 i
誌謝 ii
中文摘要 iii
Abstract v
圖次 x
第 一 章 前言 2
1.1 黏膜屏障 2
1.1.1 物理性屏障 (physical barrier) 2
1.1.2 化學性屏障 (chemical barrier) 2
1.1.3 免疫屏障 (immune barrier) 3
1.2 細胞間連接 3
1.3 緊密連接蛋白Occludin 4
1.3.1 Occludin的屏障功能 5
1.3.2 Occludin的非屏障功能 6
1.4 細胞凋亡 6
1.4.1 細胞凋亡內在途徑 7
1.4.2 細胞凋亡外在途徑 7
1.5 轉化生長因子β (transforming growth factor β, TGFβ) 8
1.5.1 TGFβ參與路徑 8
1.5.2 TGFβ受體位置、結構及其下游SMAD 12
1.5.3 TGFβ促進纖維化 13
1.5.4 TGFβ促進腫瘤侵襲和轉移 14
1.5.5 TGFβ抑制腫瘤生長 14
1.6 Occludin與SMAD3 15
1.7 目的 15
第 二 章 材料與方法 16
2.1 腸道上皮細胞培養 16
2.2 Occludin (OCLN) 基因敲低 (Knockdown) 與敲除 (Knockout) 細胞株 16
2.3 藥劑處理 17
2.4 跨上皮電阻 (Transepithelial electrical resistance, TER) 測量 17
2.5 組織特異性Occludin (Ocln) 基因敲除小鼠 18
2.6 硫酸葡聚醣誘導結腸炎疾病動物模型 18
2.7 組織均質 19
2.8 RNA萃取與濃度測量 19
2.9 反轉錄反應 (Reverse transcription, RT) 20
2.10 即時定量聚合酶連鎖反應 (Quantitative real-time PCR, qPCR) 21
2.11 蛋白質萃取與濃度測量 24
2.12 西方墨點法 (Western blot) 25
2.13 免疫螢光染色 (Immunofluorescence, IF) 27
2.14 鄰近連接測定法 (Proximity Ligation Assay, PLA) 29
2.15 顯微影像擷取與分析 31
2.16 人類基因表達資料庫 31
2.17 統計分析 32
第 三 章 結果 33
3.1 Occludin敲低與敲除之Caco-2細胞株上皮細胞屏障通透性增加 33
3.2 Occludin表現量下降使caspase-3轉錄體和蛋白質表現量隨之下降 33
3.3 TGFβ刺激不影響TGFβ受體表現量但提高與Occludin共定位現象 34
3.4 Occludin與TGFβ受體之間在上皮細胞穩定態中存在直接交互作用 35
3.5 漿膜面給予TGFβ刺激導致Occludin與TGFβ受體之間的交互作用顯著增加 35
3.6 抑制TGFβ 受體不會影響Occludin與TGFβ受體的交互作用 36
3.7 TGFβ刺激使Occludin與早期內吞標記物EEA1之間的交互作用減少 37
3.8 抑制TGFβ 受體可增加受TGFβ刺激所減少之Occludin與EEA1之間的交互作用 37
3.9 TGFβ receptor與Occludin一樣與EEA1之間具有交互作用 38
3.10 Occludin與SMAD3之間不存在直接交互作用 39
3.11 Occludin表現量降低不會影響SMAD3表現量 39
3.12 TGFβ刺激提升Occludin缺失導致之SMAD3核轉移 (nuclear translocation) 並伴隨caspase-3表現量下降 40
3.13 抑制TGFβ受體阻止TGFβ刺激導致的SMAD3核轉移 40
3.14 抑制TGFβ/SMAD將減少caspase-3表現 41
3.15 腸道上皮細胞特異性Ocln敲除小鼠 (Ocln KOIEC) 在硫酸葡聚醣誘發結腸炎中Casp3表現量降低 42
3.16 發炎性腸道疾病患者的OCLN缺失與細胞凋亡和TGFβ/SMAD訊息途徑之關聯 43
第 四 章 討論 45
第 五 章 圖表 49
第 六 章 參考文獻 102
-
dc.language.isozh_TW-
dc.title緊密連接蛋白Occludin調控上皮細胞凋亡以參與黏膜穩態之機制探討zh_TW
dc.titleThe mechanism of tight junction protein Occludin in maintaining mucosal homeostasis via epithelial apoptosisen
dc.typeThesis-
dc.date.schoolyear112-2-
dc.description.degree碩士-
dc.contributor.oralexamcommittee余佳慧;蔡丰喬;李育儒zh_TW
dc.contributor.oralexamcommitteeChia-Hui Yu;Feng-Chiao Tsai;Yu-Ru Leeen
dc.subject.keyword屏障功能,黏膜修復,上皮穩態,緊密連接,Occludin,凋亡,TGFβ,SMAD3,發炎性腸道疾病 (IBD),zh_TW
dc.subject.keywordbarrier function,mucosal repair,epithelial homeostasis,tight junctions,Occludin,apoptosis,TGFβ,SMAD3,inflammatory bowel disease (IBD),en
dc.relation.page117-
dc.identifier.doi10.6342/NTU202403615-
dc.rights.note未授權-
dc.date.accepted2024-08-07-
dc.contributor.author-college醫學院-
dc.contributor.author-dept口腔生物科學研究所-
顯示於系所單位:口腔生物科學研究所

文件中的檔案:
檔案 大小格式 
ntu-112-2.pdf
  目前未授權公開取用
42.98 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved